Integral Derivatives’s Regeneron Pharmaceuticals REGN Stock Holding History

Integral Derivatives’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	$286K	Buy	+831	New	+$289K	0.01%	520
2017 Q3	–	Sell	-807	Closed	-$384K	–	1274
2017 Q2	$396K	Buy	+807	New	+$353K	0.01%	771
2017 Q1	–	Sell	-964	Closed	-$357K	–	1331
2016 Q4	$354K	Sell	964 -680	-41%	-$259K	0.01%	835
2016 Q3	$661K	Sell	1,644 -56	-3%	-$22.5K	0.01%	548
2016 Q2	$594K	Sell	1,700 -1,713	-50%	-$660K	0.01%	557
2016 Q1	$1.23M	Buy	3,413 +1,754	+106%	+$723K	0.04%	320
2015 Q4	$901K	Buy	1,659 +1,080	+187%	+$585K	0.02%	496
2015 Q3	$269K	Buy	+579	New	+$311K	0.01%	891

Other funds holding REGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Integral Derivatives's REGN Position: Q1 2018 in Review

Integral Derivatives opened a new position in Regeneron Pharmaceuticals (REGN) in Q1 2018: 831 shares worth $286K. The stake represents 0.01% of the portfolio and ranks #520 among its holdings. This is a return to the name: Integral Derivatives previously reported a position in REGN as recently as Q2 2017.

Integral Derivatives first reported a position in REGN in Q3 2015 and has held it in 8 quarters since. The position peaked at $1.23M in Q1 2016. 620 funds tracked by Wall St. Rank hold REGN as of Q1 2018.

Integral Derivatives held 831 shares of Regeneron Pharmaceuticals worth $286K as of Q1 2018.
Regeneron Pharmaceuticals was a new Integral Derivatives position in Q1 2018.
Regeneron Pharmaceuticals made up 0.01% of Integral Derivatives's portfolio in Q1 2018, its #520 holding.
Integral Derivatives first reported a position in Regeneron Pharmaceuticals in Q3 2015 and has held it in 8 quarters since.
Integral Derivatives's Regeneron Pharmaceuticals position peaked at $1.23M in Q1 2016.
620 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2018.

Based on Integral Derivatives's 13F filing for Q1 2018, filed 19 Apr 2018.